8 completed, 7 recruiting, 2 not yet recruiting, 1 suspended. 8 Not applicable, 4 Phase 2, 2 Phase 3, 1 Phase 1, 1 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Not applicable | 8 | Completed 5, Recruiting 3 |
| Phase 2 | 4 | Recruiting 3, Not yet recruiting 1 |
| Phase 3 | 2 | Recruiting 1, Suspended 1 |
| Phase 1 | 1 | Recruiting 1 |
| Phase 4 | 1 | Not yet recruiting 1 |
Follow Dual X-ray Absorptiometry: new trials by email Literature Review of Dual X-ray Absorptiometry trials Research Report on Dual X-ray Absorptiometry
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Estrogen to Improve Quality of Life for Men With Newly Diagnosed or Recurrent Metastatic Hormone Sensitive Prostate Cancer, EQUIP Trial Androgen Receptor Pathway Inhibitor, Transdermal Estrogen, Bone Scan - Castration-Sensitive Prostate Adenocarcinoma, Metastatic Castration-Sensitive Prostate Adenocarcinoma | Phase 2 | Recruiting | Fred Hutchinson Cancer Center | 60 | 2026-12-01 | 2026-11-02 |
| Semaglutide and Structured Lifestyle Support to Improve Heart and Blood Vessel Health in Postmenopausal Obese Breast Cancer Survivors Taking Aromatase Inhibitors Biospecimen Collection, Dual X-ray Absorptiometry, Functional Assessment - Anatomic Stage I Breast Cancer AJCC v8, Anatomic Stage II Breast Cancer AJCC v8 | Phase 4 | Not yet recruiting | Mayo Clinic | 50 | 2026-09-01 | 2026-08-17 |
| Exercise Training for the Improvement of Immune Activity and Treatment Outcomes During Immunotherapy for Non-small Cell Lung Cancer, BOOST Trial Aerobic Exercise, Exercise Intervention, Educational Intervention - Lung Non-Small Cell Carcinoma | Not applicable | Recruiting | Fred Hutchinson Cancer Center | 100 | 2026-01-28 | 2026-06-23 |
| Testing Low Dose Tamoxifen for Invasive Breast Cancer, LoTam Trial Anastrozole, Letrozole, Exemestane - Anatomic Stage 0 Breast Cancer AJCC v8, Anatomic Stage 1 Breast Cancer AJCC v8 | Phase 3 | Suspended | Alliance for Clinical Trials in Oncology | 1556 | 2025-02-19 | 2026-09-02 |
| Supraphysiological Androgen to Enhance Treatment Activity in Metastatic Castration-Resistant Prostate Cancer, SPECTRA Study Biopsy Procedure, Biospecimen Collection, Bone Scan - Castration-Resistant Prostate Carcinoma, Metastatic Prostate Adenocarcinoma | Phase 2 | Recruiting | University of Washington | 69 | 2024-05-21 | 2026-07-21 |
| Vitamin D for Prostate Endocrine Therapy Biospecimen Collection, D Vitamin, Dual X-ray Absorptiometry - Stage I Prostate Cancer AJCC v8, Stage II Prostate Cancer AJCC v8 | Phase 3 | Recruiting | University of Rochester | 240 | 2023-12-14 | 2026-01-15 |
| Relugolix in Combination With Radiation Therapy for Treating Patients With High Risk Prostate Cancer Biospecimen Collection, Bone Scan, Brachytherapy - Stage IIC Prostate Cancer AJCC v8, Stage III Prostate Cancer AJCC v8 | Phase 2 | Not yet recruiting | University of Kansas Medical Center | 90 | 2023-11-20 | 2023-11-13 |
| Low-Intensity Mechanical Stimulation for Hematologic Malignancy Patients Low Intensity Vibration Therapy, Dual X-ray Absorptiometry, Biospecimen Collection - Hematopoietic and Lymphoid System Neoplasm | Not applicable | Recruiting | Roswell Park Cancer Institute | 75 | 2023-08-14 | 2026-08-21 |
| The Effects of Exercise on Immune Phenotype of Indolent Non-Hodgkin Lymphoma and Chronic Lymphocytic Leukemia Patients Biospecimen Collection, Cardiopulmonary Exercise Testing, Dual X-ray Absorptiometry - Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma, Indolent Non-hodgkin Lymphoma | Not applicable | Recruiting | Mayo Clinic | 70 | 2023-06-12 | 2026-04-09 |
| Acromegaly: Balance, Falls and Fracture Risk HR-pQCT, DXA scan, Bone microindentation - Acromegaly | Completed | Christian Alexander H Rosendal | 34 | 2023-06-02 | 2024-05-16 | |
| Tegavivint for the Treatment of Recurrent or Refractory Solid Tumors, Including Lymphomas and Desmoid Tumors Biospecimen Collection, Dual X-ray Absorptiometry, Tegavivint - Colorectal Carcinoma, Endometrial Carcinoma | Phase 1 / Phase 2 | Recruiting | Children's Oncology Group | 147 | 2021-11-08 | 2026-08-25 |
| Bone Loss in Melanoma Survivors Receiving Immunotherapy Biospecimen Collection, Dual X-ray Absorptiometry - Clinical Stage III Cutaneous Melanoma AJCC v8, Clinical Stage IV Cutaneous Melanoma AJCC v8 | Terminated | M.D. Anderson Cancer Center | 12 | 2021-05-10 | 2025-08-17 | |
| Effects of Alternative Healthy Eating Index-Based Diet on Inflammatory Markers and Breast Density in Healthy Participants Dietary Intervention, Dual X-ray Absorptiometry, Questionnaire Administration - Healthy Subject | Not applicable | Completed | Fred Hutchinson Cancer Center | 21 | 2019-10-28 | 2021-01-22 |
| Assessment of Vertebral Fracture Risk for First Time Liver Transplant Candidates Dual x-ray absorptiometry, Vertebral Fracture Assessment - Metabolic Bone Disease, Transplant-Related Disorder | Not applicable | Completed | Mayo Clinic | 52 | 2019-02-18 | 2023-05-06 |
| Role of Comorbidities in Chronic Heart Failure Study X-ray of the spine, Ambulatory blood pressure monitoring (ABPM), Dual X-ray absorptiometry - Heart Failure, Comorbidity | Completed | Medical University of Graz | 205 | 2016-09-01 | 2019-06-24 | |
| Quality of Life and Supportive Care Preferences Following Radiation Therapy in Prostate Cancer Survivors Undergo HRV and wear accelerometer to assess therapy complications, Dual X-ray Absorptiometry, Laboratory Biomarker Analysis - Prostate Carcinoma | Not applicable | Completed | Ohio State University Comprehensive Cancer Center | 6 | 2016-05-08 | 2023-09-15 |
| Effect of Cabozantinib S-Malate or Lenvatinib Mesylate on Weight and Body Composition in Patients With Metastatic Endocrine Cancer Computed Tomography, Dual X-ray Absorptiometry, Physical Examination - Differentiated Thyroid Gland Carcinoma, Malignant Adrenal Gland Pheochromocytoma | Not applicable | Completed | M.D. Anderson Cancer Center | 23 | 2015-11-16 | 2024-03-05 |
| Study of Bone Mineral Density in Women With Breast Cancer Treated With Triptorelin and Tamoxifen or Exemestane on Protocol IBCSG 25-02 laboratory biomarker analysis, dual x-ray absorptiometry - Breast Cancer, Osteoporosis | Not applicable | Completed | ETOP IBCSG Partners Foundation | 119 | 2009-08-03 | 2025-07-14 |
| S0307A, Long-Term Bone Quality in Women With Breast Cancer Enrolled on Clinical Trial SWOG-S0307 clodronate disodium, demeclocycline hydrochloride, ibandronate sodium - Breast Cancer | Withdrawn | SWOG Cancer Research Network | 2008-10-01 | 2013-04-10 | ||
| Bone Mineral Density and Cancer Recurrence in Patients With Early Stage Prostate Cancer dual x-ray absorptiometry - Osteoporosis, Prostate Cancer | Completed | University of Medicine and Dentistry of New Jersey | 27 | 2003-06-01 | 2011-08-12 |
Prostatic Neoplasms (6) · Osteoporosis (3) · Breast Neoplasms (2) · Acromegaly (1) · Bone Diseases (1) · Bone Diseases, Metabolic (1) · Breast Carcinoma In Situ (1) · Carcinoma, Hepatocellular (1) · Carcinoma, Intraductal, Noninfiltrating (1) · Carcinoma, Medullary (1) · Carcinoma, Non-Small-Cell Lung (1) · Colorectal Neoplasms (1) · Desmoid Tumors (1) · Endometrial Neoplasms (1) · Heart Failure (1)
Fred Hutchinson Cancer Center (3) · Mayo Clinic (3) · M.D. Anderson Cancer Center (2) · Alliance for Clinical Trials in Oncology (1) · Children's Oncology Group (1) · Christian Alexander H Rosendal (1) · ETOP IBCSG Partners Foundation (1) · Medical University of Graz (1) · Ohio State University Comprehensive Cancer Center (1) · Roswell Park Cancer Institute (1) · SWOG Cancer Research Network (1) · University of Kansas Medical Center (1) · University of Medicine and Dentistry of New Jersey (1) · University of Rochester (1) · University of Washington (1)
United States (17) · Australia (1) · Austria (1) · Belgium (1) · Denmark (1) · Puerto Rico (1) · Switzerland (1)
Brian Focht, PhD, FACSM (1) · Dawn Hershman, MD (1) · Dong-Woo Kang, PhD (1) · Ejigayehu G Abate, M.D (1) · Holly Harris (1) · Klemens Ablasser, MD (1) · Luke J Peppone (1) · Maria Daniela Hurtado Andrade, MD, PhD (1) · Megan Herr, MD (1) · Michael P. Gustafson, PhD (1) · Michael Schweizer (1) · Michael Schweizer, MD (1) · Naifa L Busaidy (1) · Nicolas Verheyen, MD (1) · Noha Abdelwahab Hassan (1)
K23HL183845 (1), P30CA072720 (1), P30CA168524 (1), P50CA097186 (1), R00CA287050 (1), R01CA258349 (1), U10CA032102 (1), UG1CA189961 (1), UM1CA228823 (1)